Ainsworth Sean — SEC Form 4 filings

SEC reporting owner CIK 1830296. 5 Form 4 filings on record with FilingPulse; latest filed 2026-04-22.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-06-13 to 2026-04-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Opus Genetics, Inc. (IRD)Director57

Form 4 filings — Ainsworth Sean

FiledFormIssuerReported transactionsSource
2026-04-224Opus Genetics, Inc. (IRD)Grant/award (A): 24,367 @ $0EDGAR
2026-01-054Opus Genetics, Inc. (IRD)Grant/award (A): 42,507EDGAR
2025-08-274Opus Genetics, Inc. (IRD)Grant/award (A): 86,956 @ $1.15EDGAR
2025-05-024Opus Genetics, Inc. (IRD)Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0EDGAR
2024-06-134Ocuphire Pharma, Inc. (OCUP)Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830296 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →